These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20157138)

  • 1. Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.
    Levine SJ; Wenzel SE
    Ann Intern Med; 2010 Feb; 152(4):232-7. PubMed ID: 20157138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.
    Fajt ML; Wenzel SE
    J Allergy Clin Immunol; 2015 Feb; 135(2):299-310; quiz 311. PubMed ID: 25662302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th2 cytokine antagonists: potential treatments for severe asthma.
    Hansbro PM; Scott GV; Essilfie AT; Kim RY; Starkey MR; Nguyen DH; Allen PD; Kaiko GE; Yang M; Horvat JC; Foster PS
    Expert Opin Investig Drugs; 2013 Jan; 22(1):49-69. PubMed ID: 23126660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent changes in the drug treatment of allergic asthma.
    Gibeon D; Menzies-Gow A
    Clin Med (Lond); 2013 Oct; 13(5):477-81. PubMed ID: 24115705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the interleukin pathway in the treatment of asthma.
    Chung KF
    Lancet; 2015 Sep; 386(9998):1086-96. PubMed ID: 26383000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of asthma endotypes: implications for therapy.
    Stokes JR; Casale TB
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):121-5. PubMed ID: 27499539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic and New Therapies in Asthma.
    Tabatabaian F; Ledford DK; Casale TB
    Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?
    De Ferrari L; Chiappori A; Bagnasco D; Riccio AM; Passalacqua G; Canonica GW
    Expert Rev Respir Med; 2016; 10(1):29-38. PubMed ID: 26566089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Targeted Therapies for Uncontrolled Asthma.
    Corren J
    J Allergy Clin Immunol Pract; 2019; 7(5):1394-1403. PubMed ID: 31076057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient stratification and the unmet need in asthma.
    Swedin L; Saarne T; Rehnberg M; Glader P; Niedzielska M; Johansson G; Hazon P; Catley MC
    Pharmacol Ther; 2017 Jan; 169():13-34. PubMed ID: 27373855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypes/endotypes-driven treatment in asthma.
    Braido F; Tiotiu A; Kowal K; Mihaicuta S; Novakova P; Oguzulgen IK
    Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):184-189. PubMed ID: 29601354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of allergic asthma: modulation of Th2 cells and their responses.
    Bosnjak B; Stelzmueller B; Erb KJ; Epstein MM
    Respir Res; 2011 Aug; 12(1):114. PubMed ID: 21867534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-helper type 2-driven inflammation defines major subphenotypes of asthma.
    Woodruff PG; Modrek B; Choy DF; Jia G; Abbas AR; Ellwanger A; Koth LL; Arron JR; Fahy JV
    Am J Respir Crit Care Med; 2009 Sep; 180(5):388-95. PubMed ID: 19483109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of histamine on Th1/Th2 cytokine balance.
    Packard KA; Khan MM
    Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood asthma as an allergic disease: rationale for the development of future treatment.
    Tang ML; Powell CV
    Eur J Pediatr; 2001 Dec; 160(12):696-704. PubMed ID: 11795676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma.
    Hasegawa T; Uga H; Mori A; Kurata H
    Eur Cytokine Netw; 2017 Mar; 28(1):8-18. PubMed ID: 28840844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Targets for Biological Therapies of Severe Asthma.
    Pelaia C; Crimi C; Vatrella A; Tinello C; Terracciano R; Pelaia G
    Front Immunol; 2020; 11():603312. PubMed ID: 33329598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yan-Hou-Qing formula attenuates allergic airway inflammation via up-regulation of Treg and suppressing Th2 responses in Ovalbumin-induced asthmatic mice.
    Cheng BH; Hu TY; Mo LH; Ma L; Hu WH; Li YS; Liu ZQ; Qiu SQ
    J Ethnopharmacol; 2019 Mar; 231():275-282. PubMed ID: 30496840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.